Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
American Health & Drug Benefits
|
May 4, 2017
The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives
Steven R Feldman, Bernard Goffe, Gary Rice, et al.
Arthritis Care & Research
|
August 30, 2018
Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical Trials
Philip Mease, Euthalia Roussou, Gerd-Rüdiger Burmester, et al.
Lancet (London, England)
|
January 10, 2006
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial
Stephen Tyring, Alice Gottlieb, Kim Papp, et al.
The Journal of Sexual Medicine
|
November 13, 2018
Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study
Gil Yosipovitch, Peter Foley, Caitriona Ryan, et al.
American Journal of Clinical Dermatology
|
August 7, 2022
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial
Alan Menter, Stanley Cohen, Jonathan Kay, et al.
Arthritis Care & Research
|
October 27, 2017
Trial Characteristics as Contextual Factors When Evaluating Targeted Therapies in Patients With Psoriatic Disease: A Meta-Epidemiologic Study
Christine Ballegaard, Tanja S Jørgensen, Marie Skougaard, et al.
Journal of the American Academy of Dermatology
|
October 4, 2016
Impact of ixekizumab on psoriasis itch severity and other psoriasis symptoms: Results from 3 phase III psoriasis clinical trials
Alexandra B Kimball, Thomas Luger, Alice Gottlieb, et al.
Plos One
|
June 16, 2011
Clinical symptoms of skin, nails, and joints manifest independently in patients with concomitant psoriasis and psoriatic arthritis
Knut M Wittkowski, Craig Leonardi, Alice Gottlieb, et al.
Annals of the Rheumatic Diseases
|
May 14, 2021
Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study
Philip J Mease, Saima Chohan, Ferran J Garcia Fructuoso, et al.
The Journal of Investigative Dermatology
|
February 1, 2020
A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain
Alice Gottlieb, Nicola E Natsis, Francisco Kerdel, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
American Health & Drug Benefits
|
May 4, 2017
The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives
Steven R Feldman, Bernard Goffe, Gary Rice, et al.
Arthritis Care & Research
|
August 30, 2018
Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical Trials
Philip Mease, Euthalia Roussou, Gerd-Rüdiger Burmester, et al.
Lancet (London, England)
|
January 10, 2006
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial
Stephen Tyring, Alice Gottlieb, Kim Papp, et al.
The Journal of Sexual Medicine
|
November 13, 2018
Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study
Gil Yosipovitch, Peter Foley, Caitriona Ryan, et al.
American Journal of Clinical Dermatology
|
August 7, 2022
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial
Alan Menter, Stanley Cohen, Jonathan Kay, et al.
Arthritis Care & Research
|
October 27, 2017
Trial Characteristics as Contextual Factors When Evaluating Targeted Therapies in Patients With Psoriatic Disease: A Meta-Epidemiologic Study
Christine Ballegaard, Tanja S Jørgensen, Marie Skougaard, et al.
Journal of the American Academy of Dermatology
|
October 4, 2016
Impact of ixekizumab on psoriasis itch severity and other psoriasis symptoms: Results from 3 phase III psoriasis clinical trials
Alexandra B Kimball, Thomas Luger, Alice Gottlieb, et al.
Plos One
|
June 16, 2011
Clinical symptoms of skin, nails, and joints manifest independently in patients with concomitant psoriasis and psoriatic arthritis
Knut M Wittkowski, Craig Leonardi, Alice Gottlieb, et al.
Annals of the Rheumatic Diseases
|
May 14, 2021
Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study
Philip J Mease, Saima Chohan, Ferran J Garcia Fructuoso, et al.
The Journal of Investigative Dermatology
|
February 1, 2020
A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain
Alice Gottlieb, Nicola E Natsis, Francisco Kerdel, et al.
Page
of 7